Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

More articles from Cystic fibrosis

  • A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases
    Annalisa Addante, Wilfred Raymond, Irina Gitlin, Annabelle Charbit, Xavier Orain, Aaron Wolfe Scheffler, Aditi Kuppe, Julia Duerr, Maria Daniltchenko, Marika Drescher, Simon Y. Graeber, Anne-Marie Healy, Stefan Oscarson, John V. Fahy, Marcus A. Mall
    European Respiratory Journal May 2023, 61 (5) 2202022; DOI: 10.1183/13993003.02022-2022
  • The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant
    Pierre-Régis Burgel, Isabelle Sermet-Gaudelus, Isabelle Durieu, Reem Kanaan, Julie Macey, Dominique Grenet, Michele Porzio, Nathalie Coolen-Allou, Raphael Chiron, Christophe Marguet, Benoit Douvry, Nadine Dufeu, Isabelle Danner-Boucher, Pierre Foucaud, Lydie Lemonnier, Emmanuelle Girodon, Jennifer Da Silva, Clémence Martin, on behalf of the French CF Reference Network study group, , Claire Andrejak, Pascaline Priou, Bénédicte Richaud-Thiriez, Julie Macey, Sylvie Montcouquiol, Benoit Douvry, Natacha Remus, Annlyse Fanton, Nathalie Coolen-Allou, Elsa Gachelin, Constance Vuillard, Camille Audousset, Louise Duthoit, Elisabeth Bellet-Fraysse, Jeanne Languepin, Isabelle Durieu, Raphaele Nove-Josserand, Camille Ohlmann, Quitterie Raynaud, Nadine Dufeu, Raphael Chiron, Yves Billon, Isabelle Danner-Boucher, Adrien Tissot, Sylvie Leroy, Frédérique Aubourg, Espérie Burnet, Pierre-Régis Burgel, Nicolas Carlier, Jennifer Da Silva, Isabelle Fajac, Emmanuelle Girodon, Reem Kanaan, Isabelle Honoré, Clémence Martin, Muriel Le Bourgeois, Isabelle Sermet-Gaudelus, Laurence Le Clainche-Viala, Harriet Corvol, Clémence Dehillotte, Pierre Foucaud, Lydie Lemonnier, Graziella Brinchault, Bruno Ravoninjatovo, Jean Le Bihan, Sophie Ramel, Christophe Marguet, Michele Porzio, Laurence Weiss, Dominique Grenet, Sandra de Miranda, Laure Cosson, Julie Mankikian, Delphine Pouradier
    European Respiratory Journal May 2023, 61 (5) 2202437; DOI: 10.1183/13993003.02437-2022
  • Elexacaftor/tezacaftor/ivacaftor corrects monocyte microbicidal deficiency in cystic fibrosis
    Luca Cavinato, Francesco R. Luly, Valentina Pastore, Daniele Chiappetta, Gloria Sangiorgi, Eva Ferrara, Pia Baiocchi, Giuseppe Mandarello, Giuseppe Cimino, Paola Del Porto, Fiorentina Ascenzioni
    European Respiratory Journal Apr 2023, 61 (4) 2200725; DOI: 10.1183/13993003.00725-2022
  • Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor
    Shuzhong Zhang, Chandra L. Shrestha, Frank Robledo-Avila, Devi Jaganathan, Benjamin L. Wisniewski, Nevian Brown, Hanh Pham, Katherine Carey, Amal O. Amer, Luanne Hall-Stoodley, Karen S. McCoy, Shasha Bai, Santiago Partida-Sanchez, Benjamin T. Kopp
    European Respiratory Journal Apr 2023, 61 (4) 2102861; DOI: 10.1183/13993003.02861-2021
  • CFTR variants are associated with chronic bronchitis in smokers
    Aabida Saferali, Dandi Qiao, Wonji Kim, Karen Raraigh, Hara Levy, Alejandro A. Diaz, Garry R. Cutting, Michael H. Cho, Craig P. Hersh
    European Respiratory Journal Aug 2022, 60 (2) 2101994; DOI: 10.1183/13993003.01994-2021
  • Clinical validation of digital biomarkers for paediatric patients with asthma and cystic fibrosis: potential for clinical trials and clinical care
    Matthijs D. Kruizinga, Esmée Essers, Frederik E. Stuurman, Yalçin Yavuz, Marieke L. de Kam, Ahnjili Zhuparris, Hettie M. Janssens, Iris Groothuis, Arwen J. Sprij, Marianne Nuijsink, Adam F. Cohen, Gertjan J.A. Driessen
    European Respiratory Journal Jun 2022, 59 (6) 2100208; DOI: 10.1183/13993003.00208-2021
  • Association of lung clearance index with survival in individuals with cystic fibrosis
    Johanna Manuela Kurz, Kathryn Angela Ramsey, Romy Rodriguez, Ben Spycher, Reta Fischer Biner, Philipp Latzin, Florian Singer
    European Respiratory Journal Mar 2022, 59 (3) 2100432; DOI: 10.1183/13993003.00432-2021
  • The rescue of F508del-CFTR by elexacaftor/tezacaftor/ivacaftor (Trikafta) in human airway epithelial cells is underestimated due to the presence of ivacaftor
    Frédéric Becq, Sandra Mirval, Thomas Carrez, Manuella Lévêque, Arnaud Billet, Christelle Coraux, Edouard Sage, Anne Cantereau
    European Respiratory Journal Feb 2022, 59 (2) 2100671; DOI: 10.1183/13993003.00671-2021
  • Efficacy and safety of inhaled ENaC inhibitor BI 1265162 in patients with cystic fibrosis: BALANCE-CF 1, a randomised, phase II study
    Christopher H. Goss, Isabelle Fajac, Raksha Jain, Wolfgang Seibold, Abhya Gupta, Ming-Chi Hsu, Sivagurunathan Sutharsan, Jane C. Davies, Marcus A. Mall
    European Respiratory Journal Feb 2022, 59 (2) 2100746; DOI: 10.1183/13993003.00746-2021
  • Theratyping cystic fibrosis in vitro in ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells
    Giovanni Sette, Stefania Lo Cicero, Giovanna Blaconà, Silvia Pierandrei, Sabina Maria Bruno, Valentina Salvati, Germana Castelli, Mario Falchi, Benedetta Fabrizzi, Giuseppe Cimino, Ruggero De Maria, Mauro Biffoni, Adriana Eramo, Marco Lucarelli
    European Respiratory Journal Dec 2021, 58 (6) 2100908; DOI: 10.1183/13993003.00908-2021

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 33

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society